Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

294.21 -2.93 (-0.99%)
Official Closing Price Updated: 6:30 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
2 Healthcare Stocks with Solid Fundamentals and 1 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
A Look Into Cigna Group Inc's Price Over Earnings
 
Via Benzinga
3 Growth Stocks Set to Flourish
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
2 Reasons to Like MOH and 1 to Stay Skeptical
Molina Healthcare’s stock price has taken a beating over the past six months, shedding 44.8% of its value and falling to $179.15 per share. This was partly due to its softer quarterly results and may... 
Via StockStory
Topics Supply Chain
Where Cigna Group Stands With Analysts
 
Via Benzinga
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened
Via Stocktwits
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
2 Reasons to Watch CI and 1 to Stay Cautious
Over the past six months, Cigna’s stock price fell to $301.01. Shareholders have lost 7.9% of their capital, which is disappointing considering the S&P 500 has climbed by 16%. This might have investors... 
Via StockStory
Topics Stocks Supply Chain
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices. 
Via Benzinga
2 S&P 500 Stocks to Research Further and 1 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers
Cigna's Evernorth invests $3.5 billion in Shields Health Solutions as Sycamore acquires the firm, while BofA highlights Cigna's strong growth outlook. 
Via Benzinga
2 Reasons to Watch ABT and 1 to Stay Cautious
Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during... 
Via StockStory
Topics Stocks Supply Chain
Market's Great Divide: AI Fuels Tech Surge, While Healthcare and Energy Grapple with Headwinds
The current financial market is witnessing a stark divergence in sector performance, painting a complex picture for investors and the broader economy. While the technology sector, particularly its... 
Via MarketMinute
Topics Artificial Intelligence Climate Change ETFs
Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy — Here's Where He's Investing Instead
A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of his preferred investments. 
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
 
Via Benzinga
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Looking At Cigna Group's Recent Unusual Options Activity
 
Via Benzinga
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Cigna Group Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
 
Via Benzinga
Why I Bought the Dip in UnitedHealth Group
This top health insurer scans as a downright bargain at current levels. 
Via The Motley Fool
UnitedHealth Stock Gets Fresh Fuel From Dividend Nod — Now Retail Traders Are Whispering About Warren Buffett Taking Stake
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares. 
Via Stocktwits
CI Q2 Deep Dive: Product Innovation and Margins Tested Amid Industry Pressures
Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per... 
Via StockStory
5 Insightful Analyst Questions From Cigna’s Q2 Earnings Call
Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite revenue and adjusted earnings per share both coming in ahead of Wall Street... 
Via StockStory
Topics Earnings
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Cigna (CI) Q2 Revenue Jumps 11%
Via The Motley Fool
Topics Artificial Intelligence
What 11 Analyst Ratings Have To Say About Cigna Group
 
Via Benzinga
5 Dividend Stocks With Solid Returns And More Growth Ahead
 
Via Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation. 
Via Benzinga
Trump Reportedly Taps Wall Street Banks To Explore Fannie, Freddie Public Offering Strategy — Retail Eyes Fresh Highs
According to a Bloomberg News report, Trump already met JPMorgan Chase & Co. CEO Jamie Dimon last week at the White House, followed by talks with Goldman Sachs CEO David Solomon on Thursday. 
Via Stocktwits
Topics Government
Cigna Sees Elevated Cost Trends To Continue Into Next Year
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.